News|Podcasts|June 3, 2025
S2. Ep 56: Insights From a Pharmacy Times Peer Exchange: How to Talk the Talk
Author(s)Alexandra Gerlach, Content Producer
Experts share insights on patient discussions and adverse effect management strategies in HER2 breast cancer.
Advertisement
Listen to the final episode in our Pharmacy Times Peer Exchange feature series on antibody-drug conjugates and HER2 breast cancer. In this segment, our pharmacy experts share how they have discussions with patients about treatment and interdisciplinary approaches to managing adverse effects to enhance patient care.
Advertisement
Related Content
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
White House Expands TrumpRx, Adding Over 600 Generic Medications
2
FDA Approves Immgolis and Immgolis Intri as First Biosimilars to Golimumab Reference Products for RA and UC
3
FDA Approves Baxdrostat as First-in-Class Aldosterone Synthase Inhibitor for Hypertension
4
GLP-1 Boosters: Responding to Supplement Marketing Claims and Safety Questions
5